| Literature DB >> 35480274 |
Milad Baghal Behyar1, Nasrin Shadjou1.
Abstract
During the twentieth century, ractopamine (RAC) as one of the important and frequently used feed additives and doping agents has attracted considerable attention in the animal breeding industry and sports competitions. Due to the low metabolism rate of RAC, it is accumulated in livestock tissues. By consuming food, the residues enter the human body causing hazardous side effects including tachycardia, palpitations, and headache. So, sensitive identification of this compound is desirable to combat illicit use and protect food safety. Here, a novel nanomaterial is manufactured based on the functionalization of dendritic fibrous nanosilica with dipenicillamine (KCC-1-NH-DPA). Synthesised advanced nanomaterial was used for the encapsulation of specific DNA-aptamer and incubated on the surface of gold electrode modified by poly(β-cyclodextrin) P(β-CD) which provided the high surface area, excellent mechanical and thermal stability for the dens-loading of encapsulated aptamer. The green platform was provided an efficient apta-platform for the specific recognition of RAC in human biofluids. Electroanalysis of RAC was performed based on "signal ON" protocol. The modified gold electrode by P(β-CD)-(KCC-1-NH-DPA) was used to improve the conductivity and function of the aptasensor towards sensitive identification of RAC in human real sample. Cyclic voltammetry, differential voltammetry, square wave voltammetry, and chronoamperometry techniques were exploited for the measurement of RAC in the concentration range of 0.1 fM to 0.1 mM. Furthermore, the lower limit of quantification (LLOQ) of engineered aptasensor was obtained as 0.1 fM. It is worth noting that the proposed electrochemical aptasensor showed excellent stability, selectivity and performance in standard and human plasma samples. It is important to point out that, synergetic effect of DFNS with high surface to volume, P(β-CD) as conductive substrate and selective aptamer in the fabricated biodevice lead to highly sensitive and selective biosensor for the biomedical analysis of clinical samples. This platform will be provide a new horizon for the application of advanced nanomaterials in biomedical science based POC analysis. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35480274 PMCID: PMC9041102 DOI: 10.1039/d1ra05655g
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1(A) CVs of Au electrode in the presence of β-CD solution (0.005 g + 7 mL of PBS) at a potential range of −1 to 1.5 V with a scan rate of 100 mV s−1. (B) ChAs of Au electrode modified by P(β-CD) in the presence of KCC-1-NH2-DPA (0.01 g + 10 mL deionized water) at the potential of −0.24 V during 100 s.
Scheme 1Illustration of aptasensor for the identification of RAC.
Fig. 2(A) CVs of Au electrode, P(β-CD)/Au electrode, KCC-1-NH2-DPA/P(β-CD)/Au electrode, aptamer/KCC-1-NH2-DPA/P(β-CD)/Au electrode and RAC (100 μM)/aptamer/KCC-1-NH2-DPA/P(β-CD)/Au electrode in the presence of [Fe(CN)6]3−/4− 0.01 M + 0.01 M KCl as a support electrolyte at a potential range of −1 to 1 V with a scan rate of 100 mV s−1 (B) variation of oxidation peak current versus type of electrode. (n = 3, SD = 2.14).
Comparison of analytical performance of developed aptasensor with other reported EC biosensors for the determination of RAC
| Strategy | Detection technique | Linear range (μmol L−1) | Limit of detection (μmol L−1) | Reference |
|---|---|---|---|---|
| GO/GCE | DPV | 0.074–2.96 | 0.056 |
|
| G/GNR/GCE | DPV | 0.001–2.7 | 0.00051 |
|
| MWCNT/MIM/SPE | DPV | 0.02–0.2 | 0.006 |
|
| MWCNT/GCE | DPV | 0.148–5.92 | 0.059 |
|
| CNPs/GCE | DPV | 0.002–0.03 | 0.0002 |
|
| Aptamer/KCC-1-NH2-DPA/P(β-CD)/Au electrode | CV, DPV, SWV and ChA | 1 × 102–1 × 10−10 | 1 × 10−10 | This work |
GO modified GCE.
Graphene/gold nanorod modified GCE.
Multi-wall carbon nanotubes and molecularly imprinted membranes modified screen-printed electrode.
Multi-wall carbon nanotubes modified GCE.
Carbon nanoparticle modified GCE.
Fig. 3DPVs (A), SWVs (C) and ChAs (E) of different concentrations of RAC (10−4, 10−6, 10−8,10−12, 10−14 and 10−15 M) with human plasma samples were recorded in the potential range −1 to 1 V and the scan rate of 100 mV s−1 in the presence of control electrolyte [Fe(CN)6]3−/4− 0.01 M + KCl 0.01 M and calibration curves ((B), (D), and (F) for DPV, SWV and ChA, respectively). (n = 3, SD = 2.25 for CV), (n = 3, SD = 2.29 for DPV), and (n = 3, SD = 2.36 for ChA).